Integral Diagnostics Limited
ASX:IDX.AX
2.57 (AUD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 469.697 | 440.099 | 358.739 | 348.808 | 274.081 | 232.393 | 189.399 | 179.732 | 167.77 | 151.213 | 4.12 | 3.23 |
| Cost of Revenue
| 365.894 | 342.338 | 274.894 | 256.618 | 202.018 | 141.415 | 118.162 | 114.427 | 103.771 | 92.486 | 0 | 0 |
| Gross Profit
| 103.803 | 97.761 | 83.845 | 92.19 | 72.063 | 90.978 | 71.237 | 65.305 | 63.999 | 58.727 | 4.12 | 3.23 |
| Gross Profit Ratio
| 0.221 | 0.222 | 0.234 | 0.264 | 0.263 | 0.391 | 0.376 | 0.363 | 0.381 | 0.388 | 1 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 305.804 | 285.581 | 227.002 | 207.564 | 161.196 | 146.121 | 122.633 | 118.192 | 107.13 | 0 | 0.639 | 0 |
| Selling & Marketing Expenses
| -243.915 | -227.293 | -179.414 | -163.246 | -127.537 | -122.598 | -101.702 | -98.584 | -89.35 | 0 | 0 | 0 |
| SG&A
| 61.889 | 58.288 | 47.588 | 44.318 | 33.659 | 23.523 | 20.931 | 19.608 | 17.78 | 16.166 | 0.639 | 0 |
| Other Expenses
| -2.918 | 0.663 | 2.191 | -0.152 | -3.628 | 0.073 | -2.505 | 1.2 | -6.436 | 0 | 0 | 0 |
| Operating Expenses
| 61.889 | 57.625 | 45.397 | 44.318 | 33.659 | 54.74 | 46.833 | 41.713 | 44.661 | 43.83 | 0.641 | 0 |
| Operating Income
| 41.914 | 40.136 | 38.448 | 47.872 | 38.404 | 37.873 | 28.462 | 23.688 | 26.508 | 25.073 | 3.479 | 3.23 |
| Operating Income Ratio
| 0.089 | 0.091 | 0.107 | 0.137 | 0.14 | 0.163 | 0.15 | 0.132 | 0.158 | 0.166 | 0.844 | 1 |
| Total Other Income Expenses Net
| -98.989 | -9.175 | -15.729 | -2.668 | -3.144 | -7.255 | -6.355 | -2.379 | -10.058 | -14.132 | -0.058 | 0 |
| Income Before Tax
| -57.075 | 30.961 | 22.719 | 45.204 | 35.26 | 30.618 | 22.107 | 21.309 | 16.45 | 10.941 | 3.422 | 3.23 |
| Income Before Tax Ratio
| -0.122 | 0.07 | 0.063 | 0.13 | 0.129 | 0.132 | 0.117 | 0.119 | 0.098 | 0.072 | 0.83 | 1 |
| Income Tax Expense
| 3.564 | 5.593 | 7.958 | 13.954 | 12.227 | 9.635 | 7.028 | 5.829 | 5.062 | 6.136 | 0.002 | 0 |
| Net Income
| -60.699 | 25.04 | 14.603 | 31.268 | 23.033 | 20.983 | 15.079 | 15.48 | 11.388 | 4.5 | 3.424 | 3.23 |
| Net Income Ratio
| -0.129 | 0.057 | 0.041 | 0.09 | 0.084 | 0.09 | 0.08 | 0.086 | 0.068 | 0.03 | 0.831 | 1 |
| EPS
| -0.26 | 0.11 | 0.07 | 0.16 | 0.12 | 0.1 | 0.075 | 0.11 | 0.082 | 0.031 | 0.047 | 0.044 |
| EPS Diluted
| -0.26 | 0.11 | 0.069 | 0.15 | 0.12 | 0.1 | 0.075 | 0.11 | 0.082 | 0.031 | 0.047 | 0.044 |
| EBITDA
| 89.01 | 83.622 | 75.147 | 82.786 | 64.084 | 51.382 | 38.072 | 33.518 | 35.228 | 33.679 | 3.481 | 0 |
| EBITDA Ratio
| 0.19 | 0.19 | 0.209 | 0.237 | 0.234 | 0.221 | 0.201 | 0.186 | 0.21 | 0.223 | 0.845 | 0 |